Cell Surface Markers Market: Is the Quest for "Off-the-Shelf" CAR-T Therapy Driving a Reagent Boom?

добавлена новая статья Health

2026-02-02 11:38:03 -

The explosion of interest in cell and gene therapies is fundamentally reshaping the reagents and kits segment of the industry. In 2026, the push for allogeneic, or "off-the-shelf," CAR-T treatments depends entirely on the ability to precisely screen and modify donor cells. The Cell Surface Markers Market provides the essential "quality control" tools for this process, allowing manufacturers to...

0 Комментарии 0 Поделились 44 Просмотры 0 предпросмотр